Related Experiment Video
Updated: May 11, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
Distribution of Streptococcus pneumoniae serotypes that cause parapneumonic empyema in Turkey
Mehmet Ceyhan1, Yasemin Ozsurekci, Nezahat Gürler
1Department of Pediatric Infectious Diseases, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Insights
Pediatric empyema in Turkey was primarily caused by Streptococcus pneumoniae serotypes not covered by the 7-valent pneumococcal conjugated vaccine (PCV-7). Continued surveillance is crucial for effective vaccine selection.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Vaccinology
Background:
- Streptococcus pneumoniae is a leading cause of complicated pneumonia, particularly empyema in children.
- Despite the availability of pneumococcal vaccines, pediatric parapneumonic empyema remains a significant health concern.
Purpose of the Study:
- To investigate the specific serotypes of Streptococcus pneumoniae responsible for empyema in unvaccinated children in Turkey.
- To assess the potential coverage of existing pneumococcal vaccines against these identified serotypes.
Main Methods:
- Analysis of pleural fluid samples from 156 children diagnosed with empyema across 13 hospitals in Turkey (2010-2012).
- Detection of 14 Streptococcus pneumoniae serotypes/serogroups using a Bio-Plex multiplex antigen assay.
- Evaluation of serotype coverage for PCV-7, PCV-10, and PCV-13 vaccines.
Main Results:
- Streptococcus pneumoniae serotypes were identified in 33 of 156 cases; all children were unvaccinated.
- Non-PCV-7 serotypes (1, 5, 3) were prevalent, accounting for a significant proportion of identified cases.
- PCV-7 serotypes were detected in 16.3% of cases, while PCV-13 offered 60% potential coverage.
Conclusions:
- Serotypes not included in the 7-valent pneumococcal conjugated vaccine are major contributors to pediatric empyema in the studied population.
- Active surveillance for Streptococcus pneumoniae serotypes causing empyema is essential for optimizing pneumococcal vaccine strategies.
- The findings underscore the need for updated vaccine formulations to address circulating, non-vaccine serotypes.
Abstract:
Streptococcus pneumoniae is the most common etiological cause of complicated pneumonia, including empyema. In this study, we investigated the serotypes of S. pneumoniae that cause empyema in children. One hundred fifty-six children who were diagnosed with pneumonia complicated with empyema in 13 hospitals in seven geographic regions of Turkey between 2010 and 2012 were included in this study. Pleural fluid samples were collected by thoracentesis and tested for 14 serotypes/serogroups using a Bio-Plex multiplex antigen detection assay. The serotypes of S. pneumoniae were specified in 33 of 156 samples. The mean age ± the standard deviation of the 33 patients was 6.17 ± 3.54 years (range, 0.6 to 15 years). All of the children were unvaccinated according to the vaccination reports. Eighteen of the children were male, and 15 were female. The serotypes of the non-7-valent pneumococcal conjugated vaccine (non-PCV-7), serotype 1, serotype 5, and serotype 3, were detected in eight (14.5%), seven (12.7%), and five (9.1%) of the samples, respectively. Serotypes 1 and 5 were codetected in two samples. The remaining non-PCV-7 serotypes were 8 (n = 3), 18 (n = 1), 19A (n = 1), and 7F/A (n = 1). PCV-7 serotypes 6B, 9V, 14, 19F, and 23F were detected in nine (16.3%) of the samples. The potential serotype coverages of PCV-7, PCV-10, and PCV-13 were 16.3%, 45.4%, and 60%, respectively. Pediatric parapneumonic empyema continues to be an important health problem despite the introduction of conjugated pneumococcal vaccines. Active surveillance studies are needed to monitor the change in S. pneumoniae serotypes that cause empyema in order to have a better selection of pneumococcal vaccines.
Related Concept Videos
Atypical Pneumonia
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Bacterial Phylum Spirochaetes
Bacterial Meningitis I: Introduction

